The roles of the peripheral CB1 antagonist AM6545 and the CB1 neutral antagonist AM4113 on insulin resistance development using the high-fructose/high-salt model of metabolic syndrome were investigated in the present study. The gene discussed is CNR1; the disease is metabolic syndrome.